GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » Total Long-Term Liabilities

Walvax Biotechnology Co (SZSE:300142) Total Long-Term Liabilities : ¥815 Mil (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Walvax Biotechnology Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Walvax Biotechnology Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥815 Mil.

Walvax Biotechnology Co Total Long-Term Liabilities Historical Data

The historical data trend for Walvax Biotechnology Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walvax Biotechnology Co Total Long-Term Liabilities Chart

Walvax Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 370.48 439.92 837.44 989.60 846.45

Walvax Biotechnology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 975.53 900.10 883.75 846.45 814.66

Walvax Biotechnology Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Walvax Biotechnology Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Walvax Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » Total Long-Term Liabilities
Comparable Companies
SZSE:000739 SZSE:300601 SHSE:603707 SZSE:002755 SHSE:603858 SHSE:600867 SZSE:002399 SHSE:600750 SHSE:600420 SZSE:000766 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Kexin Road, No. 395, High-tech Zone, Yunnan Province, Kunming, CHN, 650101
Website
http://www.walvax.com
Walvax Biotechnology Co Ltd is engaged in research and development, production and sales of vaccine products.
Executives
Wu Yun Yan Executives
Zhao Jin Long Executives
Yao Wei Executives
Zhou Hua Executives
Shi Jing Executives
Jiang Run Sheng Directors, executives
Gong Sun Qing Executives
Executives
Yuan Lin Executives
Fang Guo Liang Executives
Li Yun Chun Director
Huang Zhen Director
Zhang Li Secretary Dong
Yang Hong Wei Supervisors
Xu Ke Ren Executives

Walvax Biotechnology Co Headlines

No Headlines